ALVO
Price
$8.33
Change
+$0.29 (+3.61%)
Updated
Sep 5 closing price
Capitalization
2.6B
67 days until earnings call
BNXTF
Price
$0.67
Change
+$0.01 (+1.52%)
Updated
Sep 5 closing price
Capitalization
80.55M
Interact to see
Advertisement

ALVO vs BNXTF

Header iconALVO vs BNXTF Comparison
Open Charts ALVO vs BNXTFBanner chart's image
Alvotech
Price$8.33
Change+$0.29 (+3.61%)
Volume$448.25K
Capitalization2.6B
BIONXT SOLUTIONS
Price$0.67
Change+$0.01 (+1.52%)
Volume$450
Capitalization80.55M
ALVO vs BNXTF Comparison Chart in %
Loading...
ALVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BNXTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALVO vs. BNXTF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALVO is a Hold and BNXTF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (ALVO: $8.33 vs. BNXTF: $0.67)
Brand notoriety: ALVO and BNXTF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ALVO: 112% vs. BNXTF: 10%
Market capitalization -- ALVO: $2.6B vs. BNXTF: $80.55M
ALVO [@Pharmaceuticals: Generic] is valued at $2.6B. BNXTF’s [@Pharmaceuticals: Generic] market capitalization is $80.55M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALVO’s FA Score shows that 1 FA rating(s) are green whileBNXTF’s FA Score has 0 green FA rating(s).

  • ALVO’s FA Score: 1 green, 4 red.
  • BNXTF’s FA Score: 0 green, 5 red.
According to our system of comparison, ALVO is a better buy in the long-term than BNXTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALVO’s TA Score shows that 3 TA indicator(s) are bullish while BNXTF’s TA Score has 4 bullish TA indicator(s).

  • ALVO’s TA Score: 3 bullish, 2 bearish.
  • BNXTF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ALVO is a better buy in the short-term than BNXTF.

Price Growth

ALVO (@Pharmaceuticals: Generic) experienced а +3.22% price change this week, while BNXTF (@Pharmaceuticals: Generic) price change was -6.39% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Reported Earning Dates

ALVO is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALVO($2.6B) has a higher market cap than BNXTF($80.6M). BNXTF YTD gains are higher at: 167.050 vs. ALVO (-37.037). ALVO has higher annual earnings (EBITDA): 207M vs. BNXTF (-5.38M). ALVO has more cash in the bank: 151M vs. BNXTF (80.1K). BNXTF has less debt than ALVO: BNXTF (5.61M) vs ALVO (1.27B). ALVO has higher revenues than BNXTF: ALVO (560M) vs BNXTF (42K).
ALVOBNXTFALVO / BNXTF
Capitalization2.6B80.6M3,221%
EBITDA207M-5.38M-3,846%
Gain YTD-37.037167.050-22%
P/E Ratio36.22N/A-
Revenue560M42K1,333,333%
Total Cash151M80.1K188,514%
Total Debt1.27B5.61M22,586%
TECHNICAL ANALYSIS
Technical Analysis
ALVOBNXTF
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
55%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
Bearish Trend 1 day ago
49%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
45%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
55%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
66%
Bullish Trend 1 day ago
79%
Advances
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend about 1 month ago
66%
Declines
ODDS (%)
Bearish Trend 10 days ago
68%
Bearish Trend 19 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ALVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BNXTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BAYZF33.490.95
+2.92%
Bayer A.G.
TWMIF3.37N/A
N/A
Tidewater Midstream & Infrastructure Ltd.
NSLYF17.95N/A
N/A
Nestle Malaysia BHD
EXMRF12.00N/A
N/A
Exmar S.A.
NWXPF0.04N/A
N/A
Newport Exploration Ltd.

ALVO and

Correlation & Price change

A.I.dvisor tells us that ALVO and EBS have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALVO and EBS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVO
1D Price
Change %
ALVO100%
+3.61%
EBS - ALVO
27%
Poorly correlated
-0.66%
CRON - ALVO
23%
Poorly correlated
N/A
ACB - ALVO
22%
Poorly correlated
+1.66%
PAHC - ALVO
22%
Poorly correlated
+0.97%
PBH - ALVO
21%
Poorly correlated
-2.55%
More

BNXTF and

Correlation & Price change

A.I.dvisor tells us that BNXTF and TAK have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BNXTF and TAK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNXTF
1D Price
Change %
BNXTF100%
+2.55%
TAK - BNXTF
32%
Poorly correlated
+0.72%
SNOA - BNXTF
29%
Poorly correlated
+4.42%
SDZXF - BNXTF
29%
Poorly correlated
N/A
ALVO - BNXTF
13%
Poorly correlated
+3.61%
ESAIY - BNXTF
11%
Poorly correlated
+2.66%
More